Modafinil zur behandlung exzessiver tagesschläfrigkeit trotz ncpap-therapie beim obstruktiven schlafapnoe-syndrom (osas) – ergebnisse einer multizentrischen beobachtungsstudie
Zusammenfassung Fragestellung   Trotz optimierter Therapie und Ausschluss anderer Ursachen leiden etwa 10 % der Patienten mit obstruktivem Schlafapnoe-Syndrom (OSAS) weiterhin an residualer Schl�frigkeit. In einer nicht-interventionellen Studie sollte die Wirksamkeit und Vertr�glichkeit einer symptomatischen Therapie mit Modafinil bei Patienten mit OSAS und persistierender Tagesschl�frigkeit trotz optimierter
Modafinil zur behandlung exzessiver tagesschläfrigkeit trotz ncpap-therapie beim obstruktiven schlafapnoe-syndrom (osas) – ergebnisse einer multizentrischen beobachtungsstudie...

Problem Solving Meditation Posted By : Constantine George
Problems? Sleep over it and daydream the solution in less than twenty minutes. Meditation is a key practice to help you keep your mind focused on what ever you decide to think to. And an unemotional, objective mind is a lot more efficient at problem solving than
Problem Solving Meditation Posted By : Constantine George...

Potentiating Effect of Eszopiclone on GABAA Receptor-Mediated Responses in Pedunculopontine Neurons
The pedunculopontine nucleus (PPN) is part of the cholinergic arm of the reticular activating system, which is mostly active during waking and REM sleep. GABAergic modulation of this area appears to regulate sleep-wake cycles. Eszopiclone (ESZ), a nonbenzodiazepine hypnotic agent, appears to modulate GABAergic receptors. However, the action
Potentiating Effect of Eszopiclone on GABAA Receptor-Mediated Responses in Pedunculopontine Neurons...

BioAlliance Acquired European Rights For Ondansetron Oral Spray To Complement Its Franchise In Cancer Supportive Care From NovaDel Pharma Inc.
BioAlliance Pharma SA (Paris:BIO) a specialty pharmaceutical company focused on the treatment of opportunistic infections in cancer and HIV, announced that it has acquired the European commercial rights to ondansetron Oral Spray (OS) from NovaDel Pharma Inc. (Amex: NVD). Ondansetron is the leading 5-HT3 antagonist largely used to
BioAlliance Acquired European Rights For Ondansetron Oral Spray To Complement Its Franchise In Cancer Supportive Care From NovaDel Pharma Inc....

International Guidelines Will Promote Food Safety Of Plant And Animal Biotech Products
The Biotechnology Industry Organization congratulates the Codex Alimentarius Commission for approving key guidelines to further promote the safety of products from agricultural plant and animal biotechnology. The Codex Commission took final action at its 31st session in Geneva, Switzerland. More: continued here
International Guidelines Will Promote Food Safety Of Plant And Animal Biotech Products...

Genzyme And Osiris Partner To Develop And Commercialize First-In-Class Adult Stem Cell Products
Genzyme Corp. (Nasdaq: GENZ) and Osiris Therapeutics (Nasdaq: OSIR) announced today that they have entered a strategic alliance for the development and commercialization of Prochymal and Chondrogen, two novel, late-stage adult stem cell treatments that hold significant potential to treat a wide range of diseases. These stem-cell products
Genzyme And Osiris Partner To Develop And Commercialize First-In-Class Adult Stem Cell Products...